Oncology & Cancer

VEGF may not be relevant biomarker for advanced prostate cancer

The well-studied protein VEGF does not appear to have any prognostic or predictive value for men with locally advanced prostate cancer, researchers from the Department of Radiation Oncology at Thomas Jefferson University ...

Oncology & Cancer

Fasting time for tumour cells

(Medical Xpress)—Tumours need a steady supply of sufficient nutrients to be able to grow. In order to secure the nutrient availability, they secrete messenger compounds to stimulate neighbouring blood vessels to proliferate ...

Oncology & Cancer

New biomarker may help in detecting gliomas

Researchers using sophisticated genetic testing techniques have identified a promising new biomarker for diagnosis of glioma—the most common type of malignant brain tumor, reports the January issue of Neurosurgery, official ...

Ophthalmology

Novel drug may stop eye disease

(Medical Xpress)—A new drug developed by researchers from Flinders University, in partnership with collaborators in Melbourne, could hold the key to better treatment of some blinding eye diseases.

page 2 from 7